Shopping Cart
- Remove All
- Your shopping cart is currently empty
Lufotrelvir (PF-07304814) is a small molecule inhibitor of the SARS CoV-2 3CL protease for the treatment of COVID-19 with broad-spectrum anti-SARS activity for the study of novel coronavirus infections.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $48 | In Stock | |
5 mg | $113 | In Stock | |
10 mg | $196 | In Stock | |
25 mg | $393 | In Stock | |
50 mg | $588 | In Stock |
Description | Lufotrelvir (PF-07304814) is a small molecule inhibitor of the SARS CoV-2 3CL protease for the treatment of COVID-19 with broad-spectrum anti-SARS activity for the study of novel coronavirus infections. |
In vivo | After intravenous administration to rats, dogs, and monkeys, Lufotrelvir exhibits favorable cardiovascular safety and pharmacokinetic parameters[1]. |
Alias | PF-07304814 |
Molecular Weight | 552.51 |
Formula | C24H33N4O9P |
Cas No. | 2468015-78-1 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 100 mg/mL (180.99 mM), Sonification is recommended. H2O: 30 mg/mL (54.30 mM), Sonification is recommended. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.